期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
Longitudinal assessment of peripheral organ metabolism and the gut microbiota in an APP/PS1 transgenic mouse model of Alzheimer’s disease 被引量:1
1
作者 Hongli Li Jianhua Huang +4 位作者 Di Zhao lemei zhu Zheyu Zhang Min Yi Weijun Peng 《Neural Regeneration Research》 SCIE CAS 2025年第10期2982-2997,共16页
Alzheimer’s disease not only affects the brain,but also induces metabolic dysfunction in peripheral organs and alters the gut microbiota.The aim of this study was to investigate systemic changes that occur in Alzhei... Alzheimer’s disease not only affects the brain,but also induces metabolic dysfunction in peripheral organs and alters the gut microbiota.The aim of this study was to investigate systemic changes that occur in Alzheimer’s disease,in particular the association between changes in peripheral organ metabolism,changes in gut microbial composition,and Alzheimer’s disease development.To do this,we analyzed peripheral organ metabolism and the gut microbiota in amyloid precursor protein-presenilin 1(APP/PS1)transgenic and control mice at 3,6,9,and 12 months of age.Twelve-month-old APP/PS1 mice exhibited cognitive impairment,Alzheimer’s disease-related brain changes,distinctive metabolic disturbances in peripheral organs and fecal samples(as detected by untargeted metabolomics sequencing),and substantial changes in gut microbial composition compared with younger APP/PS1 mice.Notably,a strong correlation emerged between the gut microbiota and kidney metabolism in APP/PS1 mice.These findings suggest that alterations in peripheral organ metabolism and the gut microbiota are closely related to Alzheimer’s disease development,indicating potential new directions for therapeutic strategies. 展开更多
关键词 Alzheimer’s disease APP/PS1 mice brain-kidney axis gut microbiota heart-brain axis liver-brain axis lung-brain axis microbiota-gut-brain axis peripheral organ metabolism spleen-brain axis
暂未订购
Liver as a new target organ in Alzheimer's disease:insight from cholesterol metabolism and its role in amyloid-beta clearance
2
作者 Beibei Wu Yuqing Liu +4 位作者 Hongli Li lemei zhu Lingfeng Zeng Zhen Zhang Weijun Peng 《Neural Regeneration Research》 SCIE CAS 2025年第3期695-714,共20页
Alzheimer's disease,the primary cause of dementia,is characterized by neuropathologies,such as amyloid plaques,synaptic and neuronal degeneration,and neurofibrillary tangles.Although amyloid plaques are the primar... Alzheimer's disease,the primary cause of dementia,is characterized by neuropathologies,such as amyloid plaques,synaptic and neuronal degeneration,and neurofibrillary tangles.Although amyloid plaques are the primary characteristic of Alzheimer's disease in the central nervous system and peripheral organs,targeting amyloid-beta clearance in the central nervous system has shown limited clinical efficacy in Alzheimer's disease treatment.Metabolic abnormalities are commonly observed in patients with Alzheimer's disease.The liver is the primary peripheral organ involved in amyloid-beta metabolism,playing a crucial role in the pathophysiology of Alzheimer's disease.Notably,impaired cholesterol metabolism in the liver may exacerbate the development of Alzheimer's disease.In this review,we explore the underlying causes of Alzheimer's disease and elucidate the role of the liver in amyloid-beta clearance and cholesterol metabolism.Furthermore,we propose that restoring normal cholesterol metabolism in the liver could represent a promising therapeutic strategy for addressing Alzheimer's disease. 展开更多
关键词 ABCA1 Alzheimer's disease AMYLOID-BETA apolipoprotein E cholesterol metabolism LIVER liver X receptor low-density lipoprotein receptor-related protein 1 peripheral clearance tauroursodeoxycholic acid
暂未订购
Targeting ceramide-induced microglial pyroptosis:Icariin is a promising therapy for Alzheimer's disease
3
作者 Hongli Li Qiao Xiao +3 位作者 lemei zhu Jin Kang Qiong Zhan Weijun Peng 《Journal of Pharmaceutical Analysis》 2025年第4期786-803,共18页
Alzheimer's disease(AD),a progressive dementia,is one of the most common neurodegenerative diseases.Clinical trial results of amyloid-β(Aβ)and tau regulators based on the pretext of straightforward amyloid and t... Alzheimer's disease(AD),a progressive dementia,is one of the most common neurodegenerative diseases.Clinical trial results of amyloid-β(Aβ)and tau regulators based on the pretext of straightforward amyloid and tau immunotherapy were disappointing.There are currently no effective strategies for slowing the progression of AD.Herein,we spotlight the dysregulation of lipid metabolism,particularly the elevation of ceramides(Cers),as a critical yet underexplored facet of AD pathogenesis.Our study delineates the role of Cers in promoting microglial pyroptosis,a form of programmed cell death distinct from apoptosis and necroptosis,characterized by cellular swelling,and membrane rupture mediated by the NLRP3 inflammasome pathway.Utilizing both in vivo experiments with amyloid precursor protein(APP)/presenilin 1(PS1)transgenic mice and in vitro assays with BV-2 microglial cells,we investigate the activation of microglial pyroptosis by Cers and its inhibition by icariin(ICA),a flavonoid with known antioxidant and anti-inflammatory properties.Our findings reveal a significant increase in Cers levels and pyroptosis markers(NOD-like receptor family,pyrin domain containing 3(NLRP3),apoptosis-associated speck-like protein containing a caspase recruitment domain,caspase-1,gasdermin D(GSDMD),and interleukin-18(IL-18))in the brains of AD model mice,indicating a direct involvement of Cers in AD pathology through the induction of microglial pyroptosis.Conversely,ICA treatment effectively reduces these pyroptotic markers and Cer levels,thereby attenuating microglial pyroptosis and suggesting a novel therapeutic mechanism of action against AD.This study not only advances our understanding of the pathogenic role of Cers in AD but also introduces ICA as a promising candidate for AD therapy,capable of mitigating neuroinflammation and pyroptosis through the cyclooxygenase-2(COX-2)-NLRP3 inflammasome-gasdermin D(GSDMD)axis.Our results pave the way for further exploration of Cer metabolism disorders in neurodegenerative diseases and highlight the therapeutic potential of targeting microglial pyroptosis in AD. 展开更多
关键词 Alzheimer's disease CERAMIDES Microglia pyroptosis COX2 NLRP3 inflammasome ICARIIN
暂未订购
A dual-RPA based lateral flow strip for sensitive,on-site detection of CP4-EPSPS and Cry1Ab/Ac genes in genetically modified crops 被引量:1
4
作者 Jinbin Wang Yu Wang +7 位作者 Xiuwen Hu Yifan Chen Wei Jiang Xiaofeng Liu Juan Liu lemei zhu Haijuan Zeng Hua Liu 《Food Science and Human Wellness》 SCIE CSCD 2024年第1期183-190,共8页
Traditional transgenic detection methods require high test conditions and struggle to be both sensitive and efficient.In this study,a one-tube dual recombinase polymerase amplification(RPA)reaction system for CP4-EPSP... Traditional transgenic detection methods require high test conditions and struggle to be both sensitive and efficient.In this study,a one-tube dual recombinase polymerase amplification(RPA)reaction system for CP4-EPSPS and Cry1Ab/Ac was proposed and combined with a lateral flow immunochromatographic assay,named“Dual-RPA-LFD”,to visualize the dual detection of genetically modified(GM)crops.In which,the herbicide tolerance gene CP4-EPSPS and the insect resistance gene Cry1Ab/Ac were selected as targets taking into account the current status of the most widespread application of insect resistance and herbicide tolerance traits and their stacked traits.Gradient diluted plasmids,transgenic standards,and actual samples were used as templates to conduct sensitivity,specificity,and practicality assays,respectively.The constructed method achieved the visual detection of plasmid at levels as low as 100 copies,demonstrating its high sensitivity.In addition,good applicability to transgenic samples was observed,with no cross-interference between two test lines and no influence from other genes.In conclusion,this strategy achieved the expected purpose of simultaneous detection of the two popular targets in GM crops within 20 min at 37°C in a rapid,equipmentfree field manner,providing a new alternative for rapid screening for transgenic assays in the field. 展开更多
关键词 Genetically modifi ed crops On-site detection Lateral fl ow test strips Dual recombinase polymerase amplification (RPA)
在线阅读 下载PDF
Copper carbonate nanoparticles as an effective biomineralized carrier to load macromolecular drugs for multimodal therapy
5
作者 Liping Dong Jinsong Ding +3 位作者 lemei zhu Yujun Liu Xiang Gao Wenhu Zhou 《Chinese Chemical Letters》 SCIE CAS CSCD 2023年第9期204-209,共6页
Macromolecular drugs have attracted great interest as biotherapy to cure previously untreatable diseases.For clinical translation,biomacromolecules encounter several common druggability difficulties,such as in vivo in... Macromolecular drugs have attracted great interest as biotherapy to cure previously untreatable diseases.For clinical translation,biomacromolecules encounter several common druggability difficulties,such as in vivo instability and poor penetration to cross physiologic barriers,thus requiring sophisticated systems for drug delivery.Inspired by the natural biomineralization via interaction between inorganic ions and biomacromolecules,herein we rationally screened biocompatible transition metals to biomineralize with carbonate for macromolecules loading.Among the metal ions,Cu^(2+)was found to be the best candidate,and its superiority over the widely studied Ca^(2+)minerals was also demonstrated.Capitalized on this finding,copper carbonate nanoparticles were prepared via a simple mixing process to co-load glucose oxidase(GOx)and a HIF-αDNAzyme(DZ),achieving ultra-high loading capacity of 61%.Upon encapsulation into nanoparticles,enzymatic activity of both drugs was passivated to avoid potential side-effects during circulation,while the drugs could be rapidly released within 1 h in response to acidic p H to fully recover their activities.The nanoparticles could accumulate into tumor via intravenous injection,facilitate the cell membrane penetration,and release the payloads of GOx,DZ and Cu^(2+)inside cells to exert a series of anti-tumor effects.GOx caused tumor starvation by catalytic glucose consumption,and the concomitantly generated H_(2)O_(2)byproduct boosted the Cu^(2+)-mediated chemodynamic therapy(CDT).Meanwhile,the DZ silenced HIF-αexpression to sensitize both starvation therapy and CDT.As a result,a synergistic tumor growth inhibition was achieved.This work provides a simple method to prepare biomineralized nanoparticles,and offers a general approach for macromolecular drugs delivery via Cu^(2+)-based biomineralization. 展开更多
关键词 Metal ions BIOMINERALIZATION Drug delivery NANOMEDICINE Tumor therapy
原文传递
The interaction between ageing and Alzheimer’s disease:insights from the hallmarks of ageing 被引量:6
6
作者 Yuqing Liu Yejun Tan +3 位作者 Zheyu Zhang Min Yi lemei zhu Weijun Peng 《Translational Neurodegeneration》 CSCD 2024年第1期991-1022,共32页
Ageing is a crucial risk factor for Alzheimer’s disease(AD)and is characterised by systemic changes in both intracellular and extracellular microenvironments that affect the entire body instead of a single organ.Unde... Ageing is a crucial risk factor for Alzheimer’s disease(AD)and is characterised by systemic changes in both intracellular and extracellular microenvironments that affect the entire body instead of a single organ.Understanding the specific mechanisms underlying the role of ageing in disease development can facilitate the treatment of ageing-related diseases,such as AD.Signs of brain ageing have been observed in both AD patients and animal models.Alleviating the pathological changes caused by brain ageing can dramatically ameliorate the amyloid beta-and tau-induced neuropathological and memory impairments,indicating that ageing plays a crucial role in the pathophysiological process of AD.In this review,we summarize the impact of several age-related factors on AD and propose that preventing pathological changes caused by brain ageing is a promising strategy for improving cognitive health. 展开更多
关键词 Alzheimer’s disease Brain ageing Hallmarks of ageing Cell senescence Chronic inflammation Anti-ageing therapy
暂未订购
A visual,rapid,and sensitive detection platform for Vibrio parahaemolyticus based on RPA-CRISPR/Cas12a and an immunochromatographic test strip
7
作者 Jinbin Wang Danhong Xu +4 位作者 Hua Liu Juan Liu lemei zhu Haijuan Zeng Wenhui Wu 《Food Quality and Safety》 SCIE CAS CSCD 2024年第2期312-321,共10页
Objectives:Vibrio parahaemolyticus is the primary species that causes vibriosis.In this study,a point-of-care detection method was developed for V.parahaemolyticus.Materials and Methods:The detection platform targeted... Objectives:Vibrio parahaemolyticus is the primary species that causes vibriosis.In this study,a point-of-care detection method was developed for V.parahaemolyticus.Materials and Methods:The detection platform targeted the thermolabile haemolysin(tlh)gene of V.parahaemolyticus based on recombinant polymerase amplifcation(RPA)and clustered regularly spaced short palindromic repeat(CRISPR/Cas)systems.The platform was combined with an immunochromatographic test strip(ICS)that enables low-cost,simple,visual detection of V.parahaemolyticus.Results:The detection limit was 2.5×10^(2)fg/µL for plasmids and 1.4×10^(2)CFU/mL for V.parahaemolyticus.In addition,V.parahaemolyticus in salmon sashimi could be detected at a concentration of 154 CFU/g without enrichment,and the entire detection time was around 30 min.After enrichment for 6 h,2 CFU/g V.parahaemolyticus could be detected.Conclusions:Consequently,the proposed RPA-CRISPR/Cas12a-ICS platform could detect V.parahaemolyticus in seafood intuitively,quickly,and sensitively,leading to high practical application value. 展开更多
关键词 CRISPR/Cas12a immunochromatographic test strip tlh Vibrio parahaemolyticus
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部